Literature DB >> 20630873

The inherent processivity of the human de novo methyltransferase 3A (DNMT3A) is enhanced by DNMT3L.

Celeste Holz-Schietinger1, Norbert O Reich.   

Abstract

Human DNMT3A is responsible for de novo DNA cytosine methylation patterning during development. Here we show that DNMT3A methylates 5-8 CpG sites on human promoters before 50% of the initially bound enzyme dissociates from the DNA. Processive methylation is enhanced 3-fold in the presence of DNMT3L, an inactive homolog of DNMT3A, therefore providing a mechanism for the previously described DNMT3L activation of DNMT3A. DNMT3A processivity on human promoters is also regulated by DNA topology, where a 2-fold decrease in processivity was observed on supercoiled DNA in comparison with linear DNA. These results are the first observation that DNMT3A utilizes this mechanism of increasing catalytic efficiency. Processive de novo DNA methylation provides a mechanism that ensures that multiple CpG sites undergo methylation for transcriptional regulation and silencing of newly integrated viral DNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630873      PMCID: PMC2937940          DOI: 10.1074/jbc.M110.142513

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.

Authors:  H Kato; H Sumimoto; P Pognonec; C H Chen; C A Rosen; R G Roeder
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

2.  Contribution of facilitated diffusion and processive catalysis to enzyme efficiency: implications for the EcoRI restriction-modification system.

Authors:  M A Surby; N O Reich
Journal:  Biochemistry       Date:  1996-02-20       Impact factor: 3.162

3.  Kinetic measurement of the step size of DNA unwinding by Escherichia coli UvrD helicase.

Authors:  J A Ali; T M Lohman
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

4.  Spreading of DNA methylation across integrated foreign (adenovirus type 12) genomes in mammalian cells.

Authors:  G Orend; I Kuhlmann; W Doerfler
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Establishment of de novo DNA methylation patterns. Transcription factor binding and deoxycytidine methylation at CpG and non-CpG sequences in an integrated adenovirus promoter.

Authors:  M Toth; U Müller; W Doerfler
Journal:  J Mol Biol       Date:  1990-08-05       Impact factor: 5.469

6.  DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction.

Authors:  Isao Suetake; Fuminori Shinozaki; Junichi Miyagawa; Hideyuki Takeshima; Shoji Tajima
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

7.  Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro.

Authors:  Andrea K Robertson; Theresa M Geiman; Umesh T Sankpal; Gordon L Hager; Keith D Robertson
Journal:  Biochem Biophys Res Commun       Date:  2004-09-10       Impact factor: 3.575

8.  Mode of action of the Spiroplasma CpG methylase M.SssI.

Authors:  P Renbaum; A Razin
Journal:  FEBS Lett       Date:  1992-11-30       Impact factor: 4.124

9.  cis-Acting signal for inheritance of imprinted DNA methylation patterns in the preimplantation mouse embryo.

Authors:  C Y Howell; A L Steptoe; M W Miller; J R Chaillet
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

10.  Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA.

Authors:  D J Porter; S A Short; M H Hanlon; F Preugschat; J E Wilson; D H Willard; T G Consler
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  39 in total

Review 1.  DNA methylation and microRNAs in cancer.

Authors:  Xiang-Quan Li; Yuan-Yuan Guo; Wei De
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation.

Authors:  Celeste Holz-Schietinger; Doug M Matje; Norbert O Reich
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

Review 3.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

4.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

5.  Simultaneous single-molecule mapping of protein-DNA interactions and DNA methylation by MAPit.

Authors:  Carolina E Pardo; Russell P Darst; Nancy H Nabilsi; Amber L Delmas; Michael P Kladde
Journal:  Curr Protoc Mol Biol       Date:  2011-07

6.  Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer.

Authors:  Rebecca W Knackstedt; Vondina R Moseley; Michael J Wargovich
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

7.  Cooperative DNA binding and protein/DNA fiber formation increases the activity of the Dnmt3a DNA methyltransferase.

Authors:  Max Emperle; Arumugam Rajavelu; Richard Reinhardt; Renata Z Jurkowska; Albert Jeltsch
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

Review 8.  The de novo DNA methyltransferase DNMT3A in development and cancer.

Authors:  Bi-Feng Chen; Wai-Yee Chan
Journal:  Epigenetics       Date:  2014-03-03       Impact factor: 4.528

9.  The R882H substitution in the human de novo DNA methyltransferase DNMT3A disrupts allosteric regulation by the tumor supressor p53.

Authors:  Jonathan E Sandoval; Norbert O Reich
Journal:  J Biol Chem       Date:  2019-10-22       Impact factor: 5.157

10.  Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.

Authors:  Jonathan E Sandoval; Yung-Hsin Huang; Abigail Muise; Margaret A Goodell; Norbert O Reich
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.